DKA patients with acidosis and insulinopenia have mild to moderate hyperkalemia due to acidosis and insulin depletion. Insulin therapy decreases serum potassium levels. Acidosis correction, volume enlargement, and potassium replacement are commenced when serum levels drop below 5.3 mmol/l. This evidence concerns the gene INS and acidosis disorder.